| Dyax Kicks Off Fundraising Activities in Honor of First Ever HAE Day -- A ... MarketWatch (press release) (NASDAQ:DYAX) , the manufacturer of KALBITOR® (ecallantide) for the treatment of acute attacks of HAE in patients 16 years of age and older, announced a donation of $17700 to the United States Hereditary Angioedema Association (HAEA), ... See all stories on this topic » | ||
| Arcapta Neohaler Now Available for COPD Treatment news Stories Arcapta Neohaler is not indicated to treat asthma. It is also not indicated to treat acute deteriorations of COPD and should not be used as a rescue medication for acute symptoms. Arcapta Neohaler is the only once-daily, 24-hour long-acting ... See all stories on this topic » | ||
| Nurse-Initiated Steroids Improve Pediatric Asthma Care Doctors Lounge Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department, according to a study published online March 19 in Pediatrics. See all stories on this topic » |
Tuesday, March 20, 2012
acute asthma treatment
Labels:
asthma treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment